Yeast Patents (Class 424/93.51)
-
Publication number: 20140140970Abstract: An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).Type: ApplicationFiled: October 2, 2013Publication date: May 22, 2014Applicants: Children's Hospital Medical Center, Instituto Nacional de Ciencias Medicas Y Nutricion, The General Hospital CorporationInventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
-
Patent number: 8728489Abstract: Disclosed are uses of immunotherapeutic compositions in combination with Standard of Care (SOC), or interferon therapy combined with anti-viral therapy, for the improved treatment of chronic hepatitis C virus (HCV) infection and related conditions, including liver function. The compositions, kits and uses of the invention, as compared to the use of SOC therapy alone: improves the rate of early response to therapy as measured by early virologic markers (e.g., RVR and EVR), enlarges the pool of patients who will have sustained responses to therapy over the long term, offers shortened courses of therapy for certain patients, enables “rescue” of patients who are non-responders or intolerant to SOC therapy, improves liver function and/or reduces liver damage in patients, and enables the personalization of HCV therapy for a patient, which can result in dose sparing, improved patient compliance, reduced side effects, and improved long term therapeutic outcomes.Type: GrantFiled: September 18, 2009Date of Patent: May 20, 2014Assignee: GlobeImmune, Inc.Inventors: David Apelian, Richard C. Duke, Alex Franzusoff
-
Patent number: 8715716Abstract: This invention provides methods and compositions for producing reduced cholesterol animal foodstuffs and products by feeding livestock and other food-producing animals with feed supplemented with microbial cultures containing hypocholesterolemic compounds produced by microorganisms comprising said microbial cultures. The invention provides low cholesterol poultry, eggs, meat, whole milk, and dairy products.Type: GrantFiled: May 29, 2002Date of Patent: May 6, 2014Assignee: Jinis Biopharmaceuticals Co.Inventors: Seong-Tshool Hong, Hyeon-Jin Kim, Dae-Kwon Lee, Won-Young Yang
-
Publication number: 20140112985Abstract: This invention relates to prophylactic and/or therapeutic application of microorganism species that are, for example, administered orally as delayed release formulation designed to release its microbial content to the distal small intestine and/or colon in high quantities and density, which is a “normalized” approach to repopulate the colonic flora as a method of prevention and/or treatment of, for example, Clostridium difficile colitis.Type: ApplicationFiled: October 22, 2012Publication date: April 24, 2014Applicant: POLONEZ THERAPEUTICS LLCInventors: Wieslaw J. Bochenek, Michael L. Corrado
-
Publication number: 20140112899Abstract: A combination comprising an enaminocarbonyl compound of formula (I): wherein R is methyl, cyclopropyl or 2,2-difluoroethyl, and at least one biological control agent selected from bacteria, fungi or yeasts, protozoas, viruses, and entomopathogenic nematodes, and optionally an inoculant, for reducing overall damage of plants and plant parts as well as losses in harvested fruits or vegetables caused by insects, mites nematodes and phytopathogens.Type: ApplicationFiled: June 12, 2012Publication date: April 24, 2014Inventors: Peter Jeschke, Heike Hungenberg
-
Patent number: 8697425Abstract: The present invention relates to a composite yeast for high concentration alcohol fermentation, which includes thermostable Saccharomyces cerevisiae, acid protease, phytase, cellulose, ?-glucanase, and pectinase, and is suitable for the high concentration alcohol fermentation for various raw materials. In addition to normal fermentation, the composite yeast of the present invention can degrade the raw materials, increase the nutrient ingredients in the mash, promote the growth of yeast and provide stress tolerance protection.Type: GrantFiled: December 30, 2005Date of Patent: April 15, 2014Assignee: Angel Yeast Co., Ltd.Inventors: Xuefeng Yu, Zhihong Li, Minghua Yu, Juan Yao, Zhijun Li, Daiwu Liu
-
Publication number: 20140099373Abstract: The present invention relates to a combination of an anti-toxin, The present invention relates to a combination of an anti-toxin, an immunomodulator and a component that provides energy to mucosal cells, which may be useful for decreasing effects of Clostridia sp.Type: ApplicationFiled: October 2, 2013Publication date: April 10, 2014Applicant: Oil-Dri Corporation of AmericaInventors: Jonathan Broomhead, Fang Chi, Ron Cravens, George Robert Goss, Richard Jaffee, Sara LeAnn Johnston, Michael McPherson, Ronda Jean Williams
-
Patent number: 8691301Abstract: A self gassing composition comprising at least one surfactant and a fermentation base including a gas producing organism and at least one sugar is disclosed. Use of a nonionic surfactant in the self gassing composition allows the fermentation base to continue reacting and producing gas. Additionally, a personal care cleansing product and method for storing and delivering an aqueous composition having at least one surfactant and pressurized gas dissolved therein is disclosed. In one aspect, the composition is stored in an internal reservoir in a container such that when a sealing device is removed from a valveless opening, the composition foams and plumes out the opening of the container as the gas dissolved in the composition is released. In addition to the self gassing composition, a pressurized gas may be injected into a surfactant composition to produce the gas pressurized cleaning composition.Type: GrantFiled: June 30, 2008Date of Patent: April 8, 2014Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Jeffery Richard Seidling, Scott W. Wenzel, Stacy Averic Mundschau, David W. Koenig
-
Publication number: 20140079669Abstract: The present invention provides formulations and methods for preventing, suppressing, treating, or controlling pre- or post-harvest disease or decay in plants. In the inventive method, plants are contacted with a formulation including an antagonistic microorganism and a booster composition. The booster composition generally includes about 3 parts Kaolin clay, about 1 part yeast, about 1 part Yucca plant extract, and about 1 part calcium-source material. The antagonistic microorganism may be included in an amount of between about 0.02 parts and about 0.5 parts by weight of the formulation, with about 0.04 parts antagonistic microorganism being preferred in testing to date. The formulation is typically applied to the above ground structures of the plant, including its leaves, flowers, stems, trunk, blossoms and fruit.Type: ApplicationFiled: November 26, 2013Publication date: March 20, 2014Inventor: William Brower
-
Publication number: 20140065210Abstract: The present invention relates to a personal care product comprising a protein matrix wherein said protein matrix comprises at least one protein, at least one probiotic and a carrier fluid. The present invention also relates to the personal care product being a feminine care product particularly aimed at female urogenital health to treat or prevent vaginal infections. Oral and sinus infections, however, may also be benefited by the composition.Type: ApplicationFiled: August 29, 2012Publication date: March 6, 2014Inventors: David W. Koenig, Neil T. Scholl, Vasily A. Topolkaraev, Amy L. Vanden Heuvel
-
Patent number: 8663623Abstract: The present invention relates to multi purpose herbal cattle feed supplement compositions for enhancing the productivity and quality of milk by improved bioavailability/bioenhancing of nutrients. The herbal composition comprises an effective amount of an extract and/or at least one bioactive fraction or powder from herbs such as Asparagus, Withania, Lepidium, Bacopa, Nardostachys, Vetiveria, Pueraria, Emblica, Tinospora etc.; one or more additive selected from Probiotics, decorticated cotton seed extract (DCC), chelated mineral mixture, mineral nutrients, dicalcium phosphate (DCP), dolomite, calcite, vitamins and amino acids to obtain the herbal feed supplement compositions.Type: GrantFiled: October 12, 2009Date of Patent: March 4, 2014Inventor: Prashant Neminath Patil
-
Publication number: 20140056863Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid eicosapentaenoic acid. It may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, citrulline, ?-ketoglutarate, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 27, 2014Applicant: Nestec S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Publication number: 20140056862Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and ?-ketoglutarate. The composition may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, citrulline, eicosapentaenoic acid, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 27, 2014Applicant: Nestec S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Publication number: 20140037601Abstract: Nutritional compositions for improving, treating and/or preventing various medical conditions and methods of using same are provided. The medical conditions may include wounds, mucositis among others. The nutritional compositions include branched chain fatty acids and may include other functional ingredients such as, but not limited to probiotics, nucleotides and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 12, 2012Publication date: February 6, 2014Applicant: NESTEC S.A.Inventor: Norman Alan Greenberg
-
Publication number: 20140037604Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 6, 2014Applicant: NESTEC S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Patent number: 8632767Abstract: The present invention constitutes new 3-[1-(3-haloalkyl)triazolyl]phenyl sulphide derivatives of the formula (I) in which A1, A2, B0, B1, B2, B3, R1, R2 and n are as defined in the description, to their use as acaricides and insecticides for controlling animal pests, and to processes for preparing them.Type: GrantFiled: August 19, 2010Date of Patent: January 21, 2014Assignee: Bayer Intellectual Property GmbHInventors: Bernd Alig, Stefan Antons, Reiner Fischer, Norbert Lui, Adeline Köhler, Arnd Voerste
-
Publication number: 20140017291Abstract: The invention relates to porous films comprising crosslinked electrospun hydrogel fibers. Viable microbes are encapsulated within the crosslinked electrospun hydrogel fibers. The crosslinked electrospun hydrogel fibers are water insoluble and permeable. The invention also relates to methods of making and using such porous films.Type: ApplicationFiled: December 21, 2012Publication date: January 16, 2014Inventors: Devicharan Chidambaram, Ying Liu, Miriam H. Rafailovich
-
Publication number: 20140005047Abstract: The present invention relates to novel active ingredient combinations which consist of fluopyram and other known active ingredients and are very well suited for the control of animal pests, such as insects and/or unwanted acarids and/or nematodes, in foliar and soil application and/or in the treatment of seeds, and are also suitable for increasing yields.Type: ApplicationFiled: November 30, 2011Publication date: January 2, 2014Applicant: BAYER INTELLECTUAL PROPERTY GMBHInventors: Heike Hungenberg, Heiko Rieck, Robert Masters
-
Patent number: 8609084Abstract: This invention relates compositions and methods for protecting plants against various pathogenic agents such as fungi, viruses and bacteria. The invention can be used alone or in alternation and/or in combination with other plant protection means, and is suitable for the treatment of multiple plant species.Type: GrantFiled: December 21, 2006Date of Patent: December 17, 2013Assignee: Lesaffre et CompagnieInventor: Philippe Pujos
-
Publication number: 20130330309Abstract: According to a first aspect, a composition comprises selenium, vitamin C, and at least 90% by weight of native or undenatured whey protein. According to a second aspect, a composition consists of cystine, selenium and vitamin C. According to further aspects, cosmetic formulations, pharmaceutical compositions and neutraceutical powders and beverages are provided, containing the compositions described above.Type: ApplicationFiled: June 8, 2013Publication date: December 12, 2013Inventor: JOSEPH PAUL FAULKNER-EDWARDS
-
Publication number: 20130309191Abstract: Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.Type: ApplicationFiled: November 30, 2012Publication date: November 21, 2013Inventors: Peter David Johnson, Richard John Vickers, Francis Xavier Wilson, Colin Richard Dorgan, Lauren Jayne Sudlow, Stephen Paul Wren, Renate Van Well
-
Publication number: 20130302412Abstract: Compositions containing therapeutically effective amounts of transfer factor and one or more compounds selected from glucosamine salts, dimethyl glycine, chondroitin, montmoril-lonite, curcumin, hyaluronic acid, boswellic acid, superoxide dismutase, methyl sulfonyl methane and glucans. Methods of treating inflammation and arthritis with the compositions of the present invention are also disclosed.Type: ApplicationFiled: March 15, 2013Publication date: November 14, 2013Inventor: Joseph C. Ramaekers
-
Publication number: 20130302278Abstract: Improved (safer and more effective) methods of therapy using TNF-R agonists, e.g., CD40 agonists are provided. These methods provide for the addition of an amount of a type 1 interferon and/or a TLR agonist that is effective to prevent or reduce the toxicity (liver toxicity) that may otherwise result in some patients of the TNF-R agonist is used as a monotherapy (without the type 1 interferon and/or TLR agonist).Type: ApplicationFiled: April 16, 2013Publication date: November 14, 2013Inventors: Randolph J. Noelle, Ross M. Kedl, Cory L. Ahonen
-
Publication number: 20130296165Abstract: Dry stabilizing compositions for bioactive materials include sugars and hydrolyzed proteins, and may be formed into tablets or other forms providing enhanced stability for the bioactive material. Compositions containing the bioactive materials may be produced by a method that includes (a) combining the bioactive material with other ingredients in an aqueous solvent to form a viscous slurry; (b) snap-freezing the slurry in liquid nitrogen to form solid frozen particles, beads, droplets or strings; (c) primary drying by water removal under vacuum of the product of step (b) while maintaining it at a temperature above its freezing temperature; and (d) secondary drying of the product of step (c) at maximum vacuum and a temperature of 20° C. or higher for a time sufficient to reduce the water activity to below 0.3 Aw.Type: ApplicationFiled: March 25, 2013Publication date: November 7, 2013Inventors: Moti Harel, Qiong Tang, Trisha Rice, Kimberly Jennings, Brian Carpenter, Roger Drewes, Elizabeth Raditsis, January Scarbrough
-
Patent number: 8574619Abstract: A method of reducing the cholesterol level of a subject by administering to that subject quercetin, vitamin C, vitamin B3, and statin.Type: GrantFiled: September 5, 2008Date of Patent: November 5, 2013Assignee: Quercegen Pharmaceuticals, LLCInventor: Thomas Christian Lines
-
Publication number: 20130287749Abstract: The present invention relates to novel phosphonic acid formulations and to their use as slug and snail baits, and to the corresponding slug and snail baits, to a process for their preparation and to their use for controlling slugs and snails.Type: ApplicationFiled: September 30, 2011Publication date: October 31, 2013Applicant: BAYER INTELLECTUAL PROPERTY GMBHInventors: Wolfgang Wirth, Margit Doth, Sybille Lamprecht, Hubert Schmeer
-
Patent number: 8569039Abstract: A biologically pure culture of Saccharomyces cervisiae GP-01, and a method for producing Saccharomyces Cervisiae GP-01 which is ethanol-resistant and obtained by protoplast fusing Saccharomyces Cerevisiae (KCTC 7904) and Candida Ethanolica (KCTC 7181). Further, the present invention provides yeast containing the high content of organic bio-germanium (the yeast Ge-32K) and a method for producing the yeast Ge-32K, comprising adding the yeast GP-01 into a solution of sodium metagermanate (Na2GeO3) at the volume ratio of 1:0.5˜2; adding 0.1˜0.4 wt % of surfactant, instead of germanium dioxide as used in the prior arts; and cultivating an obtained broth. The obtained yeast Ge-32K contains the higher content of the organic bio-germanium than the conventional yeast as produced by using germanium dioxide.Type: GrantFiled: December 31, 2008Date of Patent: October 29, 2013Assignee: Geranti Pharm Ltd.Inventors: Tsang-Uk Sohn, Dae-Heoun Baek
-
Publication number: 20130251696Abstract: An antioxidant composition is described for reducing oxidative stress in subjects undergoing hormonal contraceptive drug treatment. In particular, said composition has proved to be particularly suitable because, as well as being surprisingly effective, it is extremely well-tolerated by the body as it contains natural components such as catechins from green tea, selenium yeast, alpha-lipoic acid, and coenzyme Q10.Type: ApplicationFiled: March 11, 2011Publication date: September 26, 2013Applicant: COR.CON. INTERNATIONAL S.R.L.Inventor: Umberto Cornelli
-
Patent number: 8540980Abstract: A controlled release delivery system composition and method applied to humans and animals, for oral, anal or vaginal administration of a biological component is disclosed. Preferably, a bacterium is delivered, and more preferably the bacterium is probiotic in nature, however, the biological component is not limited to the bacterium.Type: GrantFiled: November 27, 2012Date of Patent: September 24, 2013Assignee: TNTGamble, Inc.Inventors: Christopher London, Stephen J. Turner, Tanya Borek, Catherine Federici, Michael P. Hite
-
Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer
Patent number: 8501167Abstract: Provided herein are compositions and methods for targeted ablation of mutational escape in the face of cancer therapeutic agents. Compositions comprising the yeast-based vehicles are used in combination with other cancer therapeutic agents.Type: GrantFiled: January 17, 2008Date of Patent: August 6, 2013Assignee: GlobeImmune, Inc.Inventors: David Apelian, Alex Franzusoff, Timothy C. Rodell -
Patent number: 8496948Abstract: A cosmetic composition with superior moisturizing benefits comprising from approximately 0.3% to approximately 0.9% by weight of bio-chelated mineral blend comprising silicon, magnesium, copper, iron, zinc, and calcium, and at least approximately 85.0% by weight of a humectant blend. Preferably, the bio-chelated mineral blend comprise Saccharomyces zinc ferment, Saccharomyces copper ferment, Saccharomyces magnesium ferment, Saccharomyces iron ferment, Saccharomyces silicon ferment, and Saccharomyces calcium ferment in equal amounts, more preferably from approximately 0.05% to approximately 0.15% by weight of each component. The humectant blend preferably comprises glycerin, beet root extract, and Aloe barbadensis leaf polysaccharides.Type: GrantFiled: December 2, 2009Date of Patent: July 30, 2013Assignee: Bath and Body Works Brand Management, Inc.Inventor: Steve Harripersad
-
Patent number: 8476058Abstract: The invention relates to novel yeast strains, to the yeasts resulting from these strains, to a composition containing at least one Saccharomyces cerevisiae yeast and/or derivatives of a yeast having a particular interest as a food additive and/or probiotic and/or functional food and/or neutraceutic and/or functional ingredient and/or cosmeceutical and/or pharmaceutical active agent. The invention also relates to the use of the same in human and/or animal nutrition, or for the treatment or prevention of inflammatory diseases.Type: GrantFiled: December 12, 2008Date of Patent: July 2, 2013Assignees: Lesaffre et Compagnie, Universite du Droit et de la Sante Lille 2, Universite d 'Auvergne Clermont 1Inventors: Jean-Luc Simon, Georges Pignede, Pascal Vandekerckove, Pierre Desreumaux, Daniel Poulain, Arlette Darfeuille-Michaud, Adeline Sivignon
-
Patent number: 8470313Abstract: Disclosed are newly discovered Ras mutations and combinations of mutations, proteins and peptides and fusion proteins containing these mutations, nucleic acid molecules encoding such proteins, peptides, and fusion proteins, and a variety of tools and diagnostic, therapeutic, and screening methods associated with the use of such mutations.Type: GrantFiled: May 6, 2010Date of Patent: June 25, 2013Assignee: GlobeImmune, Inc.Inventors: Zhimin Guo, Yingnian Lu, Donald Bellgrau, Alex Franzusoff
-
Patent number: 8465761Abstract: The present invention provides compositions comprising at least one acidifying agent, at least one immune stimulating agent, at least one antioxidant, and optionally, at least one tissue regeneration agent. The compositions comprise pre-mixes for inclusion in the diets of piglets, wherein the diets have low levels of fermentable carbohydrates.Type: GrantFiled: July 1, 2008Date of Patent: June 18, 2013Assignee: Novus International, Inc.Inventors: Felipe Navarro, Robert John Harrell, Bradley V. Lawrence, Randy L. Anderson
-
Patent number: 8460649Abstract: The invention relates to a strain of Saccharomyces cerivisiae characterized in that it is selected from strain No. I-3936 deposited on Mar. 4, 2008 at the CNCM, strains No. I-3937 deposited on Mar. 4, 2008 at the CNCM, strain No. I-3938 deposited on Mar. 4, 2008 at the CNCM, and strain No. I-3939 deposited on Mar. 4, 2008 at the CNCM. The invention also relates to a phytosanitary composition and to a method for treating or protecting plants against diseases caused by pathogens, using said strain.Type: GrantFiled: January 26, 2010Date of Patent: June 11, 2013Assignee: Lesaffre et CompagnieInventors: Philippe Pujos, Didier Colavizza, Pascal Vandekerckove
-
Publication number: 20130130898Abstract: The present invention relates to compositions of fungicidally active compounds comprising at least one active compound I selected from 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (3?,4?,5?-trifluoro-biphenyl-2-yl)-amide (fluxapyroxade), bixafen, fluopyram, isopyrazam, sedaxane, penflufen and penthiopyrad and at least one further active component II as defined below.Type: ApplicationFiled: August 2, 2011Publication date: May 23, 2013Inventors: Markus Gewehr, Jochen Dietz, Egon Haden
-
Publication number: 20130129695Abstract: The invention provides methods for treating or inhibiting infection by Clostridium difficile in a subject in need of such treatment, comprising administering an effective amount of a compound binding to a CD3299 riboswitch, as well as assays for identifying compounds useful in such treatment, and the use of particular compounds in such treatment.Type: ApplicationFiled: February 4, 2011Publication date: May 23, 2013Inventor: Kenneth Blount
-
Publication number: 20130129653Abstract: The present invention is directed toward protecting the cosmetic use of at least an effective amount of a lysate of at least one microorganism of the genus Bifidobacterium species, or a fraction thereof, for preventing and/or treating body odor.Type: ApplicationFiled: April 22, 2011Publication date: May 23, 2013Applicant: L'OREALInventors: Isabelle Castiel, Audrey Gueniche, Dominique Bernard
-
Publication number: 20130115195Abstract: A dietary supplement based on fucoidan, blue-green algae, phycocyanin and phenylethylamine is fortified with one or more of curcumin, silymarin, resveratrol, astragalus root extract, astragoloside IV, vitamin D3, vitamin C, anhydrous trimethylglycine and brewers yeast to stimulate stem cell production and reduce the rate of telomere reduction or shortening. This can result in the repair of existing body cells and enhance longevity by stimulating the production of new stem cells and maintaining the telomeres on new stem cells as well as existing cells. The dietary supplement supports an increased life span by enhancing metabolic function, activating SIRT-1 anti-aging genes, and encouraging the production of new cells with longer telomeres.Type: ApplicationFiled: December 21, 2012Publication date: May 9, 2013Inventor: John V. Cappello
-
Patent number: 8425945Abstract: The present invention relates to methods for promoting dispersal of, or preventing formation of microbial biofilms, comprising: exposing a biofilm to an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent; treating a surface or medium susceptible to biofilm formation with an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent; incorporating an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent in a surface or medium susceptible to biofilm formation; or inducing the accumulation of one or more reactive oxygen or nitrogen species within microorganisms within said biofilm or capable of forming a biofilm. The invention also relates to methods for maintaining or enhancing or maintaining and enhancing the functioning of a biofilm, comprising exposing a biofilm to at least one nitric oxide scavenger, at least one antioxidant or at least one nitric oxide scavenger and at least one antioxidant.Type: GrantFiled: May 24, 2006Date of Patent: April 23, 2013Assignee: NewSouth Innovations Pty LimitedInventors: Nicolas Louis Gabriel Barraud, Jeremy Stephen Webb, Scott Alan Rice
-
Publication number: 20130095057Abstract: Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.Type: ApplicationFiled: November 30, 2012Publication date: April 18, 2013Inventor: Summit Corporation Plc
-
Publication number: 20130089532Abstract: A problem to be solved is to provide an orally ingestible composition which promotes the production of adiponectin and which is free from safety issues such as side effects and toxicity. An adiponectin production promoting composition is prepared which comprises salmon milt extract, brewer's yeast extract, avian collagen, and yeast containing mineral and having an adiponectin production promoting activity. Preferably, the salmon milt extract comprises low molecular weight components obtained by enzymatic degradation of salmon milt into oligonucleotides and oligopeptides. Preferably, the brewer's yeast extract comprises 50 to 80% of RNA. Preferably, the mineral yeast comprises, in dry yeast, 2 to 3% of zinc, 0.3 to 0.5% of copper, and 0.01 to 0.02% of selenium.Type: ApplicationFiled: May 13, 2011Publication date: April 11, 2013Inventor: Shanhua Xu
-
Publication number: 20130084271Abstract: A probiotic composition, delivery device, method of forming, and a method for delivery are disclosed. The composition may be in the form of a spray, mist, film, or the like suitable for use with any pre-formulated pet food product, whether in solid or liquid form, and further to the use of the spray directly on the coat or skin of an animal. The probiotic spray may also be applied directly into a cavity of the animal, for example into its mouth or nasal passages. The probiotic composition provides multiple strains or species of viable bacteria that provide health benefits when ingested, and is shown herein primarily for consumption by or use on/in animals, though the invention is not limited in any way to use strictly for animal intake, but may also be suitably used for human ingestion.Type: ApplicationFiled: October 3, 2012Publication date: April 4, 2013Applicant: Kelly Foods CorporationInventor: Kelly Foods Corporation
-
Patent number: 8388980Abstract: Disclosed are compositions, including vaccines, and methods for vaccinating an animal against hepatitis C virus (HCV) and for treating or preventing hepatitis C viral infection in an animal. The invention includes a variety of novel HCV fusion proteins that can be used directly as a vaccine or in conjunction with a yeast-based vaccine vehicle to elicit an immune response against HCV in an animal. The invention also includes the use of the HCV fusion gene and protein described herein in any diagnostic or therapeutic protocol for the detection and/or treatment or prevention of HCV infection.Type: GrantFiled: December 4, 2009Date of Patent: March 5, 2013Assignee: GlobeImmune, Inc.Inventors: Richard C. Duke, Alex Franzusoff, Aurelia Haller, Thomas H. King
-
Publication number: 20130052173Abstract: A method for limiting the growth of microorganisms in a biomass that can he used for, or is the result of, the production of biofuels by treating said biomass with a compound selected from the group constituted by menadione, menadione derivatives and mixtures thereof.Type: ApplicationFiled: July 2, 2010Publication date: February 28, 2013Inventor: Paolo Alberto Manzotti
-
Publication number: 20130028878Abstract: A dry yeast composition which includes 5-adenosyl-L-methionine and a thickener and has excellent storage stability. A thickener is added to a yeast cell concentrate obtained by culturing yeast which has SAMe-producing ability and collecting the cells, and the resultant mixture is dried. Thus, a dry yeast containing a high concentration of 5-adenosyl-L-methionine which has excellent storage stability and excellent bioabsorbability can be easily and profitably produced. It is hence possible to supply a market with a dry yeast composition that contains a high concentration of 5-adenosyl-L-methionine, which is useful as a water-soluble physiologically active substance, and that has excellent storage stability and bioabsorbability.Type: ApplicationFiled: April 5, 2011Publication date: January 31, 2013Applicant: MITSUBISHI GAS CHEMICAL COMPANY, INC.Inventors: Kentarou Takano, Shinyo Gayama
-
Publication number: 20130023412Abstract: Fungicidal mixtures based on azolopyrimidinylamines.Type: ApplicationFiled: March 23, 2011Publication date: January 24, 2013Applicant: BASF SEInventors: Markus Gewehr, Jordi Tormo I Blasco, Egon Haden
-
Patent number: 8343502Abstract: Compositions and methods for treating and/or preventing a variety of diseases and conditions that are amenable to immunotherapy and, in one particular embodiment, compositions and methods for treating and/or preventing cancer in an animal are described. Specifically improvements related to the use of a yeast-based vaccine comprising a yeast vehicle and an antigen that is selected to elicit an antigen-specific cellular and humoral immune response in an animal, for use in prophylactic and/or therapeutic vaccination and the prevention and/or treatment of a variety of diseases and conditions are disclosed.Type: GrantFiled: December 21, 2009Date of Patent: January 1, 2013Assignee: GlobeImmune, Inc.Inventors: Alex Franzusoff, Donald Bellgrau
-
Publication number: 20120322663Abstract: The present invention relates to formulations and methods for stabilizing and protecting of biologic materials during harsh storing and use conditions, wherein the formulations relate to embedded bioactive materials and biologics, including live bacteria, in a protective glassy matrix.Type: ApplicationFiled: January 28, 2011Publication date: December 20, 2012Inventors: Moti Harel, Roger Drewes, January Scarbrough
-
Publication number: 20120294839Abstract: Prosthetic apparatuses with probiotic microorganisms to control colonization of pathogenic bacteria are disclosed. The prosthetic apparatus may include a first portion having a first mating surface, a second portion having a second mating surface that conforms to the first mating surface, and at least one strain of probiotic microorganisms retained between the first and second mating surfaces prior to implantation of the prosthetic apparatus.Type: ApplicationFiled: February 24, 2012Publication date: November 22, 2012Applicant: ZIMMER DENTAL, INC.Inventor: John Zacharia